Skip to content

Efficiency of INTERCOAT (Oxiplex/AP Gel) in Preventing Intrauterine Adhesion Formation in Hysteroscopic Surgery

Efficiency of INTERCOAT (Oxiplex/AP Gel) in Preventing Intrauterine Adhesion Formation in Hysteroscopic Surgery - a Prospective Double Blind Randomized Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01637974
Enrollment
130
Registered
2012-07-11
Start date
2012-12-31
Completion date
2016-03-31
Last updated
2015-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asherman Syndrome, Endometrial Polyp, Uterine Myoma

Brief summary

The study purpose is to examine the influence of INTERCOAT in prevention of intra-uterine adhesions formation after any hysteroscopic surgery.

Interventions

DRUGINTERCOAT administration

Applying INTERCOAT in the intrauterine cavity at the end of the hysteroscopic surgery

Sponsors

Carmel Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 50 years * Must be able to understand, read and sign consent form

Exclusion criteria

* Signs of infection upon admission * Ongoing pregnancy * Carcinoma of the uterus or cervix * Recurrent PID * Women admitted for endometrial ablation * Women that gave birth 6 weeks ago * Women participating in another study

Design outcomes

Primary

MeasureTime frame
Presence of intra-uterine adhesions in a follow up diagnostic hysteroscopyone year

Countries

Israel

Contacts

Primary ContactMoran PAZ, M.D.
MORANPA@CLALIT.GOV.IL972-4-8250637
Backup ContactYuval Kaufman, M.D.
mdykaufman@clalit.org.il972-4-8250345

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026